Private Trust Company’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-161
| Closed | -$13.4K | – | 2551 |
|
|
2024
Q4 | $13.4K | Hold |
161
| – | – | ﹤0.01% | 1645 |
|
|
2024
Q3 | $11.8K | Hold |
161
| – | – | ﹤0.01% | 1661 |
|
|
2024
Q2 | $11K | Sell |
161
-19
| -11% | -$1.3K | ﹤0.01% | 1649 |
|
|
2024
Q1 | $12.5K | Buy |
180
+14
| +8% | +$969 | ﹤0.01% | 1591 |
|
|
2023
Q4 | $11.9K | Hold |
166
| – | – | ﹤0.01% | 1586 |
|
|
2023
Q3 | $8.65K | Hold |
166
| – | – | ﹤0.01% | 1648 |
|
|
2023
Q2 | $10.5K | Sell |
166
-5
| -3% | -$317 | ﹤0.01% | 1604 |
|
|
2023
Q1 | $9.26K | Sell |
171
-12
| -7% | -$650 | ﹤0.01% | 1610 |
|
|
2022
Q4 | $10K | Sell |
183
-28
| -13% | -$1.53K | ﹤0.01% | 1572 |
|
|
2022
Q3 | $10K | Buy |
211
+11
| +6% | +$521 | ﹤0.01% | 1471 |
|
|
2022
Q2 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 1476 |
|